Healthcare Companies' Annual Reports & Investor Relations Material

1067 Companies

SDGR

Schrödinger

Schrödinger, Inc. is a New York-based company that specializes in the development of a physics-focused computational platform for the discovery of novel molecules for drug development and materials...

Schrödinger Annual Report 2023

Healthcare Healthcare Information Services NASDAQ 201-500

TTOO

T2 Biosystems

In vitro diagnostics company T2 Biosystems, Inc. is making waves in the medical industry with its cutting-edge diagnostic products and candidates. Based in both the United States and internationall...

T2 Biosystems Annual Report 2023

Healthcare Medical Laboratories & Research NASDAQ 51-200

SBI

Sourcebio International Plc

Legg Mason Partners Fund Advisor, LLC manages the closed-ended fixed income mutual fund, Western Asset Intermediate Muni Fund Inc., alongside co-manager Western Asset Management Company. The fund f...

Sourcebio International Plc Annual Report 2021

Healthcare LSE 51-200

WFL

Wellfully

Wellfully is a company focused on developing technology that works in harmony with the human body and the environment to help individuals achieve their highest potential. They specialize in creatin...

Wellfully Annual Report 2021

Healthcare ASX 11-50

OVID

Ovid Therapeutics Inc.

Ovid Therapeutics Inc. is taking strides in the development of vital medications for patients and families dealing with epilepsies and seizure-related neurological disorders across the United State...

Ovid Therapeutics Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

OCGN

Ocugen

Ocugen Sets Sights on Curing Blindness Diseases with Gene Therapies Clinical-stage biopharmaceutical company Ocugen, Inc. is on a mission to develop gene therapies capable of curing blindness dise...

Ocugen Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

HCM

HUTCHMED (China)

Hong Kong-based HUTCHMED (China) Limited is making strides in the field of targeted therapeutics and immunotherapies for the treatment of cancer and immunological diseases. Its portfolio of drugs i...

HUTCHMED (China) Annual Report 2023

Healthcare Biotechnology NASDAQ 501-1000

IMAC

IMAC Holdings, Inc.

IMAC Holdings is a company that owns or manages 15 outpatient clinics that provide non-surgical treatments for sports and orthopedic injuries and movement-restricting diseases. The company was crea...

IMAC Holdings, Inc. Annual Report 2023

Healthcare NASDAQ 51-200

1AD

AdAlta

AdAlta is a groundbreaking biotechnology company that has developed a revolutionary platform for creating unique compounds called i-bodies. These compounds are created by mimicking the shape and st...

AdAlta Annual Report 2023

Healthcare Biotechnology ASX 1-10

NRBO

NeuroBo Pharmaceuticals, Inc.

Boston-based NeuroBo Pharmaceuticals, Inc. is leading the charge in developing and commercializing multimodal disease-modifying therapies for a range of diseases. With a focus on viral, neuropathic...

NeuroBo Pharmaceuticals, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

TTB

Total Brain Limited

Total Brain Limited is an Australian company that specializes in developing and selling brain health products. These products are sold in both the United States and Australia. Its flagship product ...

Total Brain Limited Annual Report 2021

Healthcare Healthcare Information Services ASX 51-200

ARVN

Arvinas

Arvinas, a clinical-stage biotechnology firm, is pioneering the development of therapies that degrade disease-causing proteins. The company has engineered proteolysis targeting chimeras (PROTAC) ta...

Arvinas Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

STXS

Stereotaxis

St. Louis-based Stereotaxis, Inc. is at the forefront of designing, manufacturing, and distributing robotic systems, instruments, and information systems for interventional laboratories worldwide. ...

Stereotaxis Annual Report 2023

Healthcare Medical Appliances & Equipment OTC 51-200

SPL

Santander Bank Polska

Starpharma Holdings Limited is an Australian company that specializes in the research, development, and commercialization of dendrimer products for various applications, especially in the pharmaceu...

Santander Bank Polska Annual Report 2023

Healthcare Biotechnology ASX 11-50

RYTM

Rhythm Pharmaceuticals

Rhythm Pharmaceuticals, Inc., a leader in the biopharmaceutical industry, is pioneering innovative therapeutics for rare genetic diseases of obesity. Focused on the development and commercializatio...

Rhythm Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200